616949897	616949897	CD	B-NP	O
|	|	NN	I-NP	O
YMC	YMC	NN	I-NP	O
|	|	NN	I-NP	O
12685228	12685228	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
091459	091459	CD	B-NP	O
|	|	CC	I-NP	O
10/1/2002	10/1/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
acute	acute	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2002	3/26/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/16/2002	6/16/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KASCH	KASCH	NNP	B-NP	O
,	,	,	O	O
RAYMOND	RAYMOND	NNP	B-NP	O
C	C	NNP	I-NP	O
767-21-63-5	767-21-63-5	CD	I-NP	O
Aara	Aara	NNP	I-NP	O
Well	Well	NNP	I-NP	O
Fayno	Fayno	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
3/26/02	3/26/02	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GAN	GAN	NN	B-NP	O
,	,	,	O	O
MAX	MAX	NNP	B-NP	O
BRUCE	BRUCE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
sbp	sbp	NN	I-NP	O
<	<	SYM	B-NP	O
100	100	CD	B-NP	O
FOLATE	FOLATE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ISORDIL	ISORDIL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	B-DNA
<	<	SYM	O	I-DNA
90	90	CD	B-NP	I-DNA
TRAZODONE	TRAZODONE	NN	I-NP	I-DNA
25	25	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
HS	HS	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
insomnia	insomnia	NNP	I-NP	I-DNA
ZOCOR	ZOCOR	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/26/02	3/26/02	CD	B-NP	O
by	by	IN	B-PP	O
BRECKLEY	BRECKLEY	NNP	B-NP	O
,	,	,	O	O
DEVIN	DEVIN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

DEFINITE	DEFINITE	NNP	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
CALCIUM	CALCIUM	NNP	B-NP	O
CHANNEL	CHANNEL	NNP	I-NP	O
BLOCKERS	BLOCKERS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
Activity	Activity	NN	I-NP	O
-	-	HYPH	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Friskney	Friskney	NNP	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
,	,	,	O	O
Capoten	Capoten	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
captopril	captopril	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
acute	acute	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CABG	CABG	NNP	I-NP	O
X	X	NNP	I-NP	O
3	3	CD	I-NP	O
LIMA	LIMA	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
OM	OM	NN	B-NP	O
,	,	,	O	O
RCA	RCA	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
CHOLECYSTECTOMY	CHOLECYSTECTOMY	NNP	I-NP	O
'91	'91	POS	B-NP	O
L	L	NNP	I-NP	O
Fem	Fem	NNP	I-NP	O
Aneurysm	Aneurysm	NNP	I-NP	O
Repair	Repair	NNP	I-NP	O
'91	'91	POS	B-NP	O
NIDDM	NIDDM	NNP	I-NP	O
Urinary	Urinary	NNP	I-NP	O
incontinence	incontinence	NN	I-NP	O
HTN	HTN	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
in	in	IN	B-PP	O
'73	'73	CD	B-NP	O
for	for	IN	B-PP	O
fibroids	fibroid	NNS	B-NP	O
-LRB-	-LRB-	SYM	B-VP	O
S/P	S/P	NN	B-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
PTCAs/stents	PTCAs/stent	NNS	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
Catherterization	Catherterization	NN	I-NP	O
6/2	6/2	CD	I-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-ADJP	O
to	to	TO	B-PP	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterizations	catheterization	NNS	I-NP	O
and	and	CC	I-NP	O
interventions	intervention	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
ACS	ACS	NN	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
crescendo	crescendo	NN	B-NP	O
angina	angina	NN	I-NP	O
peaking	peak	VBG	B-VP	O
with	with	IN	B-PP	O
angina	angina	NN	B-NP	O
awakening	awaken	VBG	B-VP	O
her	her	PRP	B-NP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
experienced	experience	VBD	B-VP	O
more	more	JJR	B-NP	O
rest	rest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
iv	iv	NN	B-NP	O
tng	tng	NN	I-NP	O
and	and	CC	I-NP	O
integrillin	integrillin	NN	I-NP	B-protein
,	,	,	O	O
per	per	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
on	on	IN	B-PP	O
am	am	NN	B-NP	O
of	of	IN	B-PP	O
6/2	6/2	CD	B-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-ADJP	O
to	to	TO	B-PP	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

70F	70F	NN	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
5/10	5/10	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
3/10	3/10	CD	B-NP	O
while	while	NN	I-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-NP	O
withSL	withSL	NN	I-NP	O
NTG	NTG	NN	I-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	B-protein
NSR	NSR	NN	I-NP	I-protein
with	with	IN	B-PP	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	I-NP	O
aVF	aVF	NN	I-NP	O
and	and	CC	I-NP	O
STD/TWI	STD/TWI	NN	I-NP	O
in	in	IN	B-PP	O
V3-V6	V3-V6	NN	B-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
cardiology	cardiology	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ntegrillin	ntegrillin	NN	B-NP	O
and	and	CC	O	O
taken	take	VBN	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
6/2	6/2	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

CAth	CAth	NN	B-NP	O
with	with	IN	B-PP	O
mid	mid	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
PTCA	PTCA	NN	B-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
CFX	CFX	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
marginal1	marginal1	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
marginal1	marginal1	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
RT	RT	NN	I-NP	O
PDA	PDA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
SVG	SVG	NN	I-NP	O
grafts	graft	NNS	I-NP	O
to	to	TO	B-PP	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
and	and	CC	I-NP	O
MARG1	MARG1	NN	I-NP	B-protein
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
of	of	IN	B-PP	O
LIMA	LIMA	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
sl	sl	NN	B-NP	B-protein
ntgx3	ntgx3	NN	I-NP	I-protein
,	,	,	O	O
lopressor	lopressor	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
ntg	ntg	NN	B-NP	O
gtt	gtt	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
with	with	IN	B-PP	O
0.5-1mm	0.5-1mm	JJ	B-NP	O
STD	STD	NN	I-NP	O
.	.	.	O	O

Felt	Felt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
post-stent	post-stent	JJ	B-NP	O
spasm	spasm	NN	I-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Integrillin	Integrillin	NNP	B-NP	O
continued	continue	VBD	B-VP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
additional	additional	JJ	I-NP	O
hrs	hr	NNS	I-NP	O
.	.	.	O	O

NTG	NTG	NN	B-NP	O
gtt	gtt	NN	I-NP	O
weaned	wean	VBD	B-VP	O
as	as	IN	B-SBAR	O
isordil	isordil	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BP	BP	NN	I-NP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
bp	bp	NN	I-NP	O
to	to	TO	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

Controlled	Control	VBN	B-VP	O
with	with	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
40	40	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
norvasc	norvasc	NN	B-NP	O
5	5	CD	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
.	.	.	O	O

low	low	JJ	B-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sit	VBD	B-VP	O
fat	fat	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
monitored	monitor	VBN	B-VP	O
by	by	IN	B-PP	O
FS	FS	NN	B-NP	B-protein
,	,	,	O	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
.	.	.	O	O

d/c	d/c	NN	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
plans	plan	NNS	B-NP	O
for	for	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Culpepper	Culpepper	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
medications	medication	NNS	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pellegrini	Pellegrini	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
any	any	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
and/or	and/or	CC	I-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
current	current	JJ	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Maria	Maria	NNP	I-NP	O
Guyon	Guyon	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
options	option	NNS	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
vs.	vs.	FW	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
YOUNKERS	YOUNKERS	NNS	B-NP	O
,	,	,	O	O
CAROL	CAROL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SO5	SO5	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/26/02	3/26/02	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

